Literature DB >> 2082310

The pharmacologic activity of ketorolac tromethamine.

W H Rooks1.   

Abstract

Ketorolac tromethamine is a highly potent member of a class of compounds having both analgesic and antiinflammatory activity. In animal pain models using underlying inflammation, ketorolac markedly inhibited the pain response and increased the pain threshold; it did not exhibit any narcotic or central nervous system depressant effects. It was also active in rat models of acute and chronic inflammation and pyresis. These activities are mediated primarily by potent prostaglandin cyclooxygenase inhibitory activity. Mild central nervous system and cardiovascular effects occurred only at doses far greater than those required for analgesic and antiinflammatory activity. Solutions of ketorolac tromethamine are not irritating. When given intramuscularly to rabbits (0.31-5% solutions), no drug-related irritation or changes in serum creatine phosphokinase were seen. The agent was not irritating when applied to the skin or eyes (less than or equal to 0.5% solutions) of animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2082310

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  6 in total

Review 1.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

Review 2.  Clinical pharmacokinetics of ketorolac tromethamine.

Authors:  D R Brocks; F Jamali
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 3.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03

4.  Suprachoroidal injection of ketorolac tromethamine does not cause retinal damage.

Authors:  Sumeng Liu; Wu Liu; Yaling Ma; Kegao Liu; Meizi Wang
Journal:  Neural Regen Res       Date:  2012-12-15       Impact factor: 5.135

5.  Comparison of analgesic effects of intravenous and intranasal ketorolac in patients with mandibular fracture-A Randomized Clinical Trial.

Authors:  Javad Yazdani; Reza Khorshidi-Khiavi; Saeed Nezafati; Ali Mortazavi; Farrokh Farhadi; Farhad Nojan; Milad Ghanizadeh
Journal:  J Clin Exp Dent       Date:  2019-09-01

6.  Comparison of Pain Relief from Different Intravenous Doses of Ketorolac after Reduction of Mandibular Fractures.

Authors:  Saeed Nezafati; Reza Khorshidi Khiavi; Seyyed Sina Mirinejhad; Dawood Aghamoh Ammadi; Milad Ghanizadeh
Journal:  J Clin Diagn Res       Date:  2017-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.